Session information:
Session:
Date: Monday, May 4, 2026
Time: 14:30 – 15:15 CET
Panel Discussion: Optimizing digital endpoint strategies for success
Selecting the right clinical trial endpoints is essential for achieving study scientific objectives, regulatory success, investor confidence and efficient trial execution. This panel discussion will explore best practices for determining the optimal strategy to meet these goals while balancing feasibility and cost. Attendees will also gain insight into selecting and overseeing a CRO partner effectively. Comprised of senior management from a CRO, biotech company and an endpoint solutions vendor, the panel will provide diverse perspectives. Audience participation and Q&A will be encouraged.
Moderator:
- Todd Rudo, M.D. – EVP, Chief Medical Officer at Clario
Panelists:
- Florian Vogl, M.D., Ph.D. – Chief Medical Officer at Tolremo Therapeutics
- Lewis Cameron – CEO at Evestia Clinical CRO
- John Ohrn – SVP, Global Partnerships at Clario
- Chris Clendening – SVP, Biotech Operations and Product Management at Clario
Meet with us at Swiss Biotech Day 2026
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.